| Item Type | Name |
|
Concept
|
Adaptation, Physiological
|
|
Concept
|
Aged
|
|
Concept
|
Aged, 80 and over
|
|
Concept
|
Eflornithine
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Anesthesia
|
|
Concept
|
Anesthetics
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Antibodies, Monoclonal
|
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
|
Concept
|
Anus Neoplasms
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
Biopsy
|
|
Concept
|
Blood Cell Count
|
|
Concept
|
Body Weight
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Bridged-Ring Compounds
|
|
Concept
|
Carcinoma, Intraductal, Noninfiltrating
|
|
Concept
|
Cell Count
|
|
Concept
|
Uterine Cervical Neoplasms
|
|
Concept
|
Cholangiopancreatography, Endoscopic Retrograde
|
|
Concept
|
Cholelithiasis
|
|
Concept
|
Colon
|
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Complement System Proteins
|
|
Concept
|
Connecticut
|
|
Concept
|
Continuity of Patient Care
|
|
Concept
|
Cost-Benefit Analysis
|
|
Concept
|
Cross-Sectional Studies
|
|
Concept
|
Diagnosis, Differential
|
|
Concept
|
Doxorubicin
|
|
Concept
|
Drug Therapy, Computer-Assisted
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
Gallbladder
|
|
Concept
|
T-Lymphocytes, Helper-Inducer
|
|
Concept
|
Histones
|
|
Concept
|
Humans
|
|
Concept
|
Immunoglobulin G
|
|
Concept
|
Ileum
|
|
Concept
|
Imidazoles
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Interleukin-2
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Health Knowledge, Attitudes, Practice
|
|
Concept
|
Leukocytes, Mononuclear
|
|
Concept
|
Longitudinal Studies
|
|
Concept
|
Lymphocytes
|
|
Concept
|
Middle Aged
|
|
Concept
|
Neutropenia
|
|
Concept
|
Obesity
|
|
Concept
|
Sphincter of Oddi
|
|
Concept
|
Ornithine
|
|
Concept
|
Phosphorylation
|
|
Concept
|
Prospective Studies
|
|
Concept
|
Quinazolines
|
|
Concept
|
Quinolines
|
|
Concept
|
Rats, Inbred Strains
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Rhode Island
|
|
Concept
|
Tamoxifen
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
United States
|
|
Concept
|
Mesna
|
|
Concept
|
Epirubicin
|
|
Concept
|
Cohort Studies
|
|
Concept
|
Signal Transduction
|
|
Concept
|
Biomarkers
|
|
Concept
|
Down-Regulation
|
|
Concept
|
Gated Blood-Pool Imaging
|
|
Concept
|
Cell Hypoxia
|
|
Concept
|
Multivariate Analysis
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Mice, SCID
|
|
Concept
|
Chemotherapy, Adjuvant
|
|
Concept
|
Cholecystectomy, Laparoscopic
|
|
Concept
|
Telemedicine
|
|
Concept
|
Cost of Illness
|
|
Concept
|
Sequence Homology, Amino Acid
|
|
Concept
|
Carcinoma, Ductal, Breast
|
|
Concept
|
Carcinoma, Lobular
|
|
Concept
|
Fee-for-Service Plans
|
|
Concept
|
Receptor, ErbB-2
|
|
Concept
|
Antineoplastic Agents, Hormonal
|
|
Concept
|
CD59 Antigens
|
|
Concept
|
CD55 Antigens
|
|
Concept
|
Telomerase
|
|
Concept
|
BRCA1 Protein
|
|
Concept
|
Topotecan
|
|
Concept
|
Neoadjuvant Therapy
|
|
Concept
|
Internet
|
|
Concept
|
Angiogenesis Inhibitors
|
|
Concept
|
Sentinel Lymph Node Biopsy
|
|
Concept
|
BRCA2 Protein
|
|
Concept
|
Disclosure
|
|
Concept
|
RNA, Small Interfering
|
|
Concept
|
Proteomics
|
|
Concept
|
Gallstones
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Mice
|
|
Concept
|
Rats
|
|
Concept
|
Membrane Cofactor Protein
|
|
Concept
|
Cardiotoxins
|
|
Concept
|
Medication Adherence
|
|
Concept
|
Young Adult
|
|
Concept
|
Patient Preference
|
|
Concept
|
Class I Phosphatidylinositol 3-Kinases
|
|
Concept
|
Antibodies, Monoclonal, Murine-Derived
|
|
Concept
|
Chemoradiotherapy
|
|
Concept
|
Text Messaging
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Antibodies, Monoclonal, Humanized
|
|
Academic Article
|
Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer.
|
|
Academic Article
|
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
|
|
Academic Article
|
Hepatic failure and hepatorenal syndrome secondary to erlotinib: a possible etiology of complications in a patient with pancreatic cancer.
|
|
Academic Article
|
Prolonged progression-free survival in a patient with triple-negative breast cancer metastatic to the liver after chemotherapy and local radiation therapy.
|
|
Academic Article
|
Impact of financial burden of cancer on survivors' quality of life.
|
|
Academic Article
|
Quantitative measurements of HER2 and phospho-HER2 expression: correlation with pathologic response to neoadjuvant chemotherapy and trastuzumab.
|
|
Academic Article
|
Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.
|
|
Academic Article
|
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy.
|
|
Academic Article
|
Systematic approach to providing breast cancer survivors with survivorship care plans: a feasibility study.
|
|
Academic Article
|
Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
|
|
Academic Article
|
Breast sentinel lymph node dissection before preoperative chemotherapy.
|
|
Academic Article
|
The prognostic and predictive values of circulating HER-2/neu extracellular domain in patients with metastatic breast cancer.
|
|
Academic Article
|
DTCs/CTCs in breast cancer: five decades later.
|
|
Academic Article
|
Brief-exposure to preoperative bevacizumab reveals a TGF-? signature predictive of response in HER2-negative breast cancers.
|
|
Academic Article
|
Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter.
|
|
Academic Article
|
Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.
|
|
Academic Article
|
Prospective assessment of the decision-making impact of the Breast Cancer Index in recommending extended adjuvant endocrine therapy for patients with early-stage ER-positive breast cancer.
|
|
Academic Article
|
Association of 21-gene recurrence score assay and adjuvant chemotherapy use in the medicare population, 2008-2011.
|
|
Academic Article
|
Anthracycline-induced cardiotoxicity: risk assessment and management.
|
|
Academic Article
|
Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer.
|
|
Academic Article
|
New Strategies in Breast Cancer: Immunotherapy.
|
|
Academic Article
|
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
|
|
Academic Article
|
Ocular complications of cancer therapy: a primer for the ophthalmologist treating cancer patients.
|
|
Academic Article
|
Patient preferences regarding incidental genomic findings discovered during tumor profiling.
|
|
Academic Article
|
Mutation based treatment recommendations from next generation sequencing data: a comparison of web tools.
|
|
Academic Article
|
The cost of breast cancer screening in the Medicare population.
|
|
Academic Article
|
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
|
|
Academic Article
|
Five-year update of an expanded phase II study of dose-dense and -intense doxorubicin, paclitaxel and cyclophosphamide (ATC) in high-risk breast cancer.
|
|
Academic Article
|
Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
|
|
Academic Article
|
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
|
|
Academic Article
|
Chemotherapy Agents With Known Cardiovascular Side Effects and Their Anesthetic Implications.
|
|
Academic Article
|
Longitudinally collected CTCs and CTC-clusters and clinical outcomes of metastatic breast cancer.
|
|
Academic Article
|
Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.
|
|
Academic Article
|
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.
|
|
Academic Article
|
Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancer.
|
|
Academic Article
|
A Case of Carcinocythemia: De Novo Hormone Receptor-positive Metastatic Breast Cancer Presenting With Circulating Tumor Cells Mimicking an Acute Leukemia.
|
|
Academic Article
|
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer.
|
|
Academic Article
|
Breast cancer patients with brain metastasis undergoing GKRS.
|
|
Academic Article
|
First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors.
|
|
Academic Article
|
Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA.
|
|
Academic Article
|
Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer.
|
|
Academic Article
|
Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy.
|
|
Concept
|
Triple Negative Breast Neoplasms
|
|
Concept
|
Drug-Related Side Effects and Adverse Reactions
|
|
Concept
|
Poly(ADP-ribose) Polymerase Inhibitors
|
|
Concept
|
Trastuzumab
|
|
Concept
|
Liquid Biopsy
|
|
Concept
|
Survivorship
|
|
Concept
|
Bevacizumab
|
|
Concept
|
Circulating Tumor DNA
|
|
Concept
|
Erlotinib Hydrochloride
|
|
Concept
|
Cardiotoxicity
|
|
Academic Article
|
Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
|
|
Academic Article
|
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
|
|
Academic Article
|
Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer.
|
|
Academic Article
|
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.
|
|
Academic Article
|
A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study.
|
|
Academic Article
|
Correction: A Telehealth-Delivered Tai Chi Intervention (TaiChi4Joint) for Managing Aromatase Inhibitor-Induced Arthralgia in Patients With Breast Cancer During COVID-19: Longitudinal Pilot Study.
|
|
Academic Article
|
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
|
|
Academic Article
|
PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
|
|
Academic Article
|
Coverage for evidence-based cancer survivorship care services.
|
|
Academic Article
|
Preoperative ultrasonography and prediction of technical difficulties during laparoscopic cholecystectomy.
|
|
Academic Article
|
Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.
|
|
Academic Article
|
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
|
|
Academic Article
|
Selective use of perioperative ERCP in patients undergoing laparoscopic cholecystectomy.
|
|
Academic Article
|
Efficacy and tolerability of combination cisplatin and ifosfamide chemotherapy with vaginal cuff brachytherapy in the first line treatment of uterine carcinosarcoma.
|
|
Academic Article
|
Potentiation of 1,2-dimethylhydrazine-induced anal carcinoma by epidermal growth factor in mice.
|
|
Academic Article
|
In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma.
|